We are live on ! Find out more
GDRX icon

GoodRx Holdings

192 hedge funds and large institutions have $5.14B invested in GoodRx Holdings in 2020 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 18

67% more first-time investments, than exits

New positions opened: 107 | Existing positions closed: 64

50% more funds holding in top 10

Funds holding in top 10: 69 (+3)

29% more funds holding

Funds holding: 149192 (+43)

15.89% less ownership

Funds ownership: 305.43%289.54% (-16%)

24% less capital invested

Capital invested by funds: $6.73B → $5.14B (-$1.59B)

54% less call options, than puts

Call options by funds: $34.7M | Put options by funds: $76M

Holders
192
Holders Change
+43
Holders Change %
+28.86%
% of All Funds
3.4%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
107
Increased
51
Reduced
18
Closed
64
Calls
$34.7M
Puts
$76M
Net Calls
-$41.4M
Net Calls Change
-$39M
Name Holding Trade Value Shares
Change
Change in
Stake
GGHC
101
Gilder Gagnon Howe & Co
New York
$645K +$504K +10,980 +220%
Cetera Investment Advisers
102
Cetera Investment Advisers
Illinois
$642K +$731K +15,921 New
AMC
103
Asset Management Corp
Illinois
$632K +$382K +8,325 +130%
BRA
104
Blue Rock Advisors
Minnesota
$620K +$706K +15,361 New
RC
105
RBF Capital
California
$605K +$689K +15,000 New
FMT
106
First Mercantile Trust
Tennessee
$581K +$331K +7,200 +100%
US Bancorp
107
US Bancorp
Minnesota
$574K +$218K +4,752 +50%
JG
108
Jefferies Group
New York
$567K +$646K +14,058 New
CW
109
CreativeOne Wealth
Kansas
$549K +$625K +13,600 New
FDS
110
First Dallas Securities
Texas
$547K +$623K +13,550 New
NA
111
NewEdge Advisors
Louisiana
$494K +$562K +12,236 New
BAM
112
Blueshift Asset Management
New Jersey
$485K +$553K +12,028 New
APA
113
American Portfolios Advisors
New York
$475K +$493K +10,725 +1,017%
SPPAM
114
Summit Partners Public Asset Management
Massachusetts
$455K -$783K -17,043 -60%
MCC
115
Malaga Cove Capital
California
$448K +$500K +10,894 New
MFG
116
Magnus Financial Group
New York
$444K +$505K +11,000 New
OGC
117
One68 Global Capital
New York
$432K +$492K +10,708 New
CIBC World Market
118
CIBC World Market
Ontario, Canada
$387K +$441K +9,600 New
HighTower Advisors
119
HighTower Advisors
Illinois
$386K +$442K +9,626 New
BCI
120
Brinker Capital Investments
Pennsylvania
$381K +$434K +9,438 New
Millennium Management
121
Millennium Management
New York
$374K -$28.4M -617,300 -99%
Creative Planning
122
Creative Planning
Kansas
$369K -$158K -3,446 -27%
KPW
123
Kore Private Wealth
New York
$315K +$358K +7,800 New
RJFSA
124
Raymond James Financial Services Advisors
Florida
$311K +$354K +7,711 New
BRWA
125
B. Riley Wealth Advisors
Florida
$310K +$352K +7,668 New

GDRX Hedge Fund Activity: Q4 2020 in Review

192 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2020, worth a combined $5.14B — down 24% from $6.73B a quarter earlier.

Buyers outnumbered sellers: 107 funds opened new GDRX positions and 64 closed out — a net gain of 43 holders — while 51 added to existing stakes and 18 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $104M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $125M sold.

  • 192 institutional investors held GoodRx Holdings (GDRX) as of Q4 2020, up from 149 in Q3 2020.
  • Funds reported $5.14B of GoodRx Holdings stock for Q4 2020, down 24% quarter-over-quarter.
  • 107 funds opened new GoodRx Holdings positions in Q4 2020 and 64 closed out, a net change of +43 holders.
  • The largest GoodRx Holdings buyer in Q4 2020 was Goldman Sachs, an estimated $104M added.
  • The largest GoodRx Holdings seller in Q4 2020 was T. Rowe Price Associates, an estimated $125M sold.

Based on aggregated 13F filings for Q4 2020.